MARK NELSON, MD
Ophthalmology Physician · TACOMA, WA
Individual Active NPI 1689647109
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,253 | 107,082 | $11,489,004 | $5,397,692 | $4,258,787 |
| 2023 | 1,426 | 84,905 | $11,194,544 | $5,580,993 | $4,400,838 |
| 2022 | 1,407 | 24,409 | $10,397,080 | $5,201,551 | $4,100,545 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 96,480 | $34 | $27 |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 2,700 | $147 | $116 |
| 67028 | Injection of drug into eye | 1,991 | $132 | $107 |
| 92134 | Imaging of retina | 1,776 | $43 | $34 |
| J0178 | Injection, aflibercept, 1 mg | 1,066 | $825 | $647 |
| 92250 | Photography of the retina | 838 | $39 | $30 |
| 92014 | Established patient complete exam of visual system | 790 | $134 | $101 |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | 322 | $202 | $159 |
| 92012 | Established patient problem focused exam of visual system | 306 | $95 | $74 |
| J0177 | Injection, aflibercept hd, 1 mg | 184 | $331 | $263 |
| 99204 | New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 93 | $176 | $133 |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | 68 | $175 | $136 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | 00043072 | WA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Washington
- NPI 1013279298
- NPI 1477902765
- NPI 1124050117
- NPI 1508817594
- NPI 1215322573
- NPI 1437386737
- NPI 1629661541
- NPI 1396890653
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.